Evaluation of 18F-FAPI-42-RGD as a novel dual-targeting PET tracer in gastric cancer xenograft models
The dual-targeting PET tracer <sup>18</sup>F-FAPI-42-RGD demonstrated significantly enhanced tumor uptake in GC models, along with a clearer background compared to <sup>18</sup>F-FAPI-42. This indicates its superior diagnostic performance, suggesting its potential for clinical translation in the imaging and diagnosis of GC.
Authors
- Zhao Yong-sheng (ORCID: https://orcid.org/0000-0001-5432-2847)
Institutions
- Anhui Medical University (CN)
- Peking University Shenzhen Hospital (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- American Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2025-01-01
- DOI
- https://doi.org/10.62347/gtzz9726
- Citations
- 3
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 3.14